Javascript must be enabled to continue!
Dynamics within tetraspanin pairs affect MHC class II expression
View through CrossRef
Late endosomal multivesicular bodies (MVBs) are complicated organelles with various subdomains located at the limiting membrane and the internal vesicles (ILVs). ILVs accumulate tetraspanins such as CD63 and CD82 that might form protein assemblies, including major histocompatibility complex class II (MHC-II) and its chaperone human leukocyte antigen (HLA)-DM. Here, we studied the effect of four late endosomal tetraspanin proteins on MHC-II expression. Silencing CD9, CD63 and CD81 enhanced MHC-II expression whereas silencing CD82 did not. No effect on peptide loading was observed. Using confocal FRET technology, we measured the dynamics of CD63 and CD82 interaction with MHC-II and its chaperone HLA-DM. CD63–CD82 interactions remained unaltered in the two MVB subdomains whereas the interactions between CD63 or CD82 homologous pairs changed. CD63 stably associated with MHC-II, and CD82 with HLA-DM, on both MVB subdomains whereas the CD82–MHC-II and CD63–HLA-DM interactions changed. These data visualize for the first time the protein dynamics of tetraspanin assemblies in MVB subdomains. CD63, unlike CD82, stably interacts with MHC-II at both MVB subdomains and controls MHC-II expression.
The Company of Biologists
Title: Dynamics within tetraspanin pairs affect MHC class II expression
Description:
Late endosomal multivesicular bodies (MVBs) are complicated organelles with various subdomains located at the limiting membrane and the internal vesicles (ILVs).
ILVs accumulate tetraspanins such as CD63 and CD82 that might form protein assemblies, including major histocompatibility complex class II (MHC-II) and its chaperone human leukocyte antigen (HLA)-DM.
Here, we studied the effect of four late endosomal tetraspanin proteins on MHC-II expression.
Silencing CD9, CD63 and CD81 enhanced MHC-II expression whereas silencing CD82 did not.
No effect on peptide loading was observed.
Using confocal FRET technology, we measured the dynamics of CD63 and CD82 interaction with MHC-II and its chaperone HLA-DM.
CD63–CD82 interactions remained unaltered in the two MVB subdomains whereas the interactions between CD63 or CD82 homologous pairs changed.
CD63 stably associated with MHC-II, and CD82 with HLA-DM, on both MVB subdomains whereas the CD82–MHC-II and CD63–HLA-DM interactions changed.
These data visualize for the first time the protein dynamics of tetraspanin assemblies in MVB subdomains.
CD63, unlike CD82, stably interacts with MHC-II at both MVB subdomains and controls MHC-II expression.
Related Results
Relationship Domain of Form Six Teachers Thinking in Teaching with External Factors of Form Six Teachers
Relationship Domain of Form Six Teachers Thinking in Teaching with External Factors of Form Six Teachers
<!--[if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:RelyOnVML /> <o:AllowPNG /> </o:OfficeDocumentSettings> </xml><![endif]--> &l...
Tetraspanin immunocapture phenotypes extracellular vesicles according to biofluid source but may limit identification of multiplexed cancer biomarkers
Tetraspanin immunocapture phenotypes extracellular vesicles according to biofluid source but may limit identification of multiplexed cancer biomarkers
AbstractTetraspanin expression of extracellular vesicles (EVs) is often used as a surrogate for their general detection and classification from background contaminants. This common...
SPECIFICATION FOR TESTING AUTOMOTIVE MINIATURE BULBS
SPECIFICATION FOR TESTING AUTOMOTIVE MINIATURE BULBS
<div class="section abstract">
<div class="htmlview paragraph">The procedures contained in this specification cover the laboratory testing of miniature incandescent b...
Abstract PS12-04: HDACi combined with anthracycline elicits interactions between MHC-II+ triple-negative breast cancer and CD69+CD4+Trm orchestrating synergistic immunotherapy
Abstract PS12-04: HDACi combined with anthracycline elicits interactions between MHC-II+ triple-negative breast cancer and CD69+CD4+Trm orchestrating synergistic immunotherapy
Abstract
Background: Early TNBC (eTNBC) lacks biomarkers for predicting the benefits of immune checkpoint blockade (ICB). Therefore, identifying indicators for the h...
Castration prevents suppression of MHC class II (Ia) expression on macrophages after trauma-hemorrhage
Castration prevents suppression of MHC class II (Ia) expression on macrophages after trauma-hemorrhage
Several studies indicate that cell-mediated immune responses, i.e., macrophage (MΦ) cytokine release capacities, myosin heavy chain (MHC) class II (Ia) expression, etc., are suppre...
Balancing selection, genetic drift, and human‐mediated introgression interplay to shape MHC (functional) diversity in Mediterranean brown trout
Balancing selection, genetic drift, and human‐mediated introgression interplay to shape MHC (functional) diversity in Mediterranean brown trout
AbstractThe extraordinary polymorphism of major histocompatibility complex (MHC) genes is considered a paradigm of pathogen‐mediated balancing selection, although empirical evidenc...
Abstract 2687: Immunopotentiator, protein-bound polysaccharide K, is efficient for advanced gastric cancer with negative expression of MHC Class I
Abstract 2687: Immunopotentiator, protein-bound polysaccharide K, is efficient for advanced gastric cancer with negative expression of MHC Class I
Abstract
It has been reported that down-regulation of MHC class I in cancer cells was associated with poor prognosis of gastrointestinal cancer, because of immunolog...
Abstract LB367: Effects of modulation of ERAP1 activity in antigen processing and presentation
Abstract LB367: Effects of modulation of ERAP1 activity in antigen processing and presentation
Abstract
ERAP1 is an enzyme that plays a key role in the antigen processing and presentation pathway as an editor of the peptide repertoire, allowing for the binding...

